SHALBY
Shalby Limited (SHALBY) Stock Analysis
Shalby Limited operates a chain of multispecialty hospitals offering orthopedics, joint replacement, and broad clinical services. It has expanded hospitals and clinics across India with focus on elective surgery excellence. The company is known for high-volume joint replacement programs. It is listed on Indian stock exchanges.
Healthcare › Medical Care Facilities
₹133.50
-0.82% 1W | -45.80% 52W
Market Cap
1.4k CR
P/E Ratio
38.1
52W High
₹255.3
52W Low
₹125.8
Div. Yield
0%
Beta
0.6
50 DMA
₹147.7
200 DMA
₹159.3
Profit Margin
3.3%
Inst. Own.
0.1%
✅ BOUNCE FROM SUPPORT
✅ BOUNCE FROM SUPPORT
Fundamentals
Profit & Loss
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 235 | 238 | 216 | 244 | 279 | 268 | 276 | 265 | 296 | 285 | 272 | 287 | 331 |
| Expenses | 192 | 185 | 174 | 205 | 234 | 235 | 242 | 244 | 255 | 244 | 242 | 258 | 290 |
| Operating Profit | 43 | 53 | 42 | 39 | 45 | 33 | 34 | 21 | 42 | 42 | 30 | 29 | 42 |
| OPM % | 18% | 22% | 20% | 16% | 16% | 12% | 12% | 8% | 14% | 15% | 11% | 10% | 13% |
| Other Income | 5 | 5 | 5 | 5 | 10 | 7 | 5 | 5 | 7 | 4 | 7 | 8 | 7 |
| Interest | 3 | 3 | 4 | 6 | 8 | 9 | 11 | 11 | 9 | 10 | 11 | 9 | 11 |
| Depreciation | 12 | 12 | 12 | 16 | 16 | 17 | 16 | 16 | 17 | 17 | 18 | 18 | 19 |
| Profit before tax | 33 | 43 | 31 | 22 | 30 | 14 | 12 | -1 | 23 | 19 | 9 | 10 | 20 |
| Tax % | 37% | 35% | 38% | 26% | 52% | 83% | 124% | 1,547% | 66% | 62% | 86% | -92% | 47% |
| Net Profit | 21 | 28 | 19 | 16 | 15 | 2 | -3 | -12 | 8 | 7 | 1 | 18 | 10 |
| EPS in Rs | 1.93 | 2.55 | 1.77 | 1.54 | 1.45 | 0.31 | -0.17 | -1.02 | 0.83 | 0.78 | 0.16 | 1.70 | 1.00 |
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 275 | 290 | 324 | 378 | 462 | 487 | 431 | 699 | 805 | 934 | 1,087 | 1,141 | 1,176 |
| Expenses | 207 | 235 | 252 | 299 | 379 | 404 | 342 | 577 | 667 | 755 | 952 | 996 | 1,033 |
| Operating Profit | 68 | 56 | 71 | 79 | 83 | 83 | 89 | 122 | 138 | 179 | 135 | 145 | 143 |
| OPM % | 25% | 19% | 22% | 21% | 18% | 17% | 21% | 17% | 17% | 19% | 12% | 13% | 12% |
| Other Income | 2 | 2 | 7 | 10 | 9 | 17 | 8 | 8 | 22 | 19 | 28 | 27 | 27 |
| Interest | 5 | 10 | 11 | 12 | 9 | 7 | 5 | 8 | 11 | 18 | 41 | 41 | 40 |
| Depreciation | 21 | 11 | 17 | 23 | 33 | 36 | 37 | 43 | 48 | 52 | 66 | 70 | 72 |
| Profit before tax | 43 | 36 | 50 | 54 | 50 | 57 | 55 | 79 | 102 | 128 | 56 | 61 | 58 |
| Tax % | 43% | -1% | 43% | 27% | 37% | 51% | 23% | 32% | 34% | 35% | 97% | 43% | |
| Net Profit | 25 | 36 | 29 | 39 | 32 | 28 | 42 | 54 | 68 | 84 | 2 | 35 | 38 |
| EPS in Rs | 7.36 | 4.30 | 3.40 | 3.65 | 2.93 | 2.55 | 3.93 | 5.01 | 6.27 | 7.78 | 0.58 | 3.46 | 3.64 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 17% | 20% | 25% | 20% | 19% | 15% | 0% | 0% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | 12.0% | 22.0% | 15.0% |
| Profit CAGR | -28.0% | -11.0% | -4.0% |
Shareholding Pattern
Promoters74.27%
FIIs5.21%
DIIs0.19%
Public19.65%
Promoters74.33%
FIIs4.63%
DIIs0.19%
Public20.18%
Promoters74.33%
FIIs4.47%
DIIs0.19%
Public20.36%
Promoters74.33%
FIIs4.36%
DIIs0.25%
Public20.41%
Promoters74.33%
FIIs4.47%
DIIs0.30%
Public20.26%
Promoters74.12%
FIIs3.92%
Public21.09%
Promoters74.24%
FIIs4.88%
Public20.13%
Promoters74.27%
FIIs4.54%
DIIs0.18%
Public20.33%
Promoters74.33%
FIIs4.36%
DIIs0.25%
Public20.41%
Promoters74.33%
FIIs4.47%
DIIs0.30%
Public20.26%
SHALBY
Holdings Analysis
Key strengths & risk signals
48
Overall
53
Fundamental
44
Technical
Risks (4)
Cannot calculate PEG - insufficient growth data.
POOR YEAR! Stock declined 45.8% in the last year.
WEAK POSITION! Current price (133.5) is below both moving averages.
WEAK! Trading at 5.9% of 52W range - near yearly lows.
Strengths (4)
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
LOW VOLATILITY! Beta of 0.60 - stable stock, less market risk.
TESTING SUPPORT! Stock is at key support level.
APPROACHING OVERSOLD! RSI at 38.4 - watch for reversal.
Fundamental & Technical Analysis
48Overall
53Fundamental
44Technical
Fundamental Breakdown
Growth Quality
13/30
Revenue CAGR: 12.4% (GOOD, 11/15). Profit CAGR: -18.0% (DECLINING, 2/15).
Profit Margin
2/10
LOW MARGIN! 3.3% profit margin - thin profits.
PEG Valuation
1/10
Cannot calculate PEG - insufficient growth data.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
14/20
MODERATE PUBLIC HOLDING! 21.0% public ownership - balanced ownership structure.
Stability Index
10/10
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
Technical Breakdown
Moving Averages
5/10
BEARISH TREND! 50-day average (147.7) is below 200-day average (159.3) - negative signal.
Price Position
2/10
WEAK POSITION! Current price (133.5) is below both moving averages.
Trend Pattern
16/20
TESTING SUPPORT! Stock is at key support level.
52W Performance
0/10
POOR YEAR! Stock declined 45.8% in the last year.
Volume Sentiment
10/30
BEARISH SENTIMENT! In last 30 days: 11 up days, 19 down days. Avg volume on up days: 79,960 vs down days: 124,504. Ratio: 0.64x
RSI
4/5
APPROACHING OVERSOLD! RSI at 38.4 - watch for reversal.
52W Range
1/5
WEAK! Trading at 5.9% of 52W range - near yearly lows.
Momentum
1/5
NEGATIVE MOMENTUM! Price declined across timeframes - down 0.8% (1 week), 7.8% (1 month), 19.8% (3 months).
Beta
5/5
LOW VOLATILITY! Beta of 0.60 - stable stock, less market risk.
SHALBY
Concall / Investor Presentation
Earnings call transcripts & AI summaries
| Quarter | Concall | Summary |
|---|---|---|
| Q4FY262026-06-02 | Concall PDF | |
| Q3FY262026-02-18 | Concall PDF | |
| Q2FY262025-11-20 | Concall PDF |
Peer Comparison
Healthcare · Medical Care Facilities · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SHALBY | ₹133.50 | 38.1 | 3.3% | 12.4% | -18.0% | -45.8% | 48 | BOUNCE FROM SUPPORT | +21.3% | -41.0% | +11.7% | +15.2% |
| GKSL | ₹194.70 | 76.6 | 15.7% | -10.9% | 32.7% | +74.6% | 78 | BOUNCE FROM SUPPORT | +8.3% | +4.0% | +124.2% | +12.1% |
| GPTHEALTH | ₹141.20 | 24.5 | 9.6% | 9.6% | 2.7% | -4.1% | 64 | BREAKDOWN | +64.9% | -13.0% | +17.8% | -0.2% |
| MAXIND | ₹159.20 | – | -55.4% | -1.8% | – | -25.8% | 52 | BREAKOUT | +41.8% | +88.1% | +62.7% | -9.0% |
| GAUDIUMIVF | ₹105.50 | 31.1 | 21.9% | 33.1% | 21.8% | +31.1% | 72 | BREAKDOWN | -41.9% | -78.6% | +9.0% | -36.2% |
| LOTUSEYE | ₹111.80 | 1398.1 | 0.3% | 4.5% | -73.0% | -12.5% | 45 | BOUNCE FROM SUPPORT | +20.0% | -300.0% | +26.7% | +25.7% |
| INDRAMEDCO | ₹327.80 | 16 | 12.3% | 10.2% | 28.7% | -41.0% | 52 | APPROACHING SUPPORT | +8.3% | +33.8% | +11.3% | +11.3% |
| JSLL | ₹384.70 | 20.3 | 27.8% | 57.7% | 87.3% | -47.2% | 63 | BREAKDOWN | +28.5% | +46.1% | +28.7% | +4.1% |
Data from TradeAlone · Updated daily
No news tagged for SHALBY yet.
